Literature DB >> 18782611

Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin.

Ying Liu1, Ping Zhang, Nianping Feng, Xin Zhang, Shan Wu, Jihui Zhao.   

Abstract

The objective of this study was to optimize and characterize an oridonin self-microemulsifying drug delivery system (SMEDDS) formulation. A central composite design (CCD) was used to investigate the influence of factors (oil percentage and surfactant to co-surfactant ratio (Sur/Co-s ratio)) on the responses including droplet size, polydispersity, equilibrium solubility and in situ intestine absorption rate. Furthermore, the desirability function approach was applied to obtain the best compromise among the multiple responses. It was found that oil percentage played a significant role on the droplet size and polydispersity. The drug equilibrium solubility was mainly contributed to oil percentage and less to Sur/Co-s ratio. The in situ intestinal absorption was influenced by both of the two factors, whereas the oil percentage played a more important role in absorption. The practical response values under the optimized formulation were in good accordance with the predicted values. Our results demonstrate CCD is of value in optimizing the SMEDDS formulation and understanding the effects of formulation compositions on SMEDDS properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782611     DOI: 10.1016/j.ijpharm.2008.08.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  20 in total

1.  Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

Authors:  Ahmed Abd Elbary; Ahmed A Aboelwafa; Ibrahim M Al Sharabi
Journal:  AAPS PharmSciTech       Date:  2011-10-29       Impact factor: 3.246

2.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

3.  Pharmacological and pharmacokinetic studies with vitamin D-loaded nanoemulsions in asthma model.

Authors:  Tang Wei-hong; Guan Min-chang; Xu Zhen; Sun Jie
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 4.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

5.  Anti-inflammatory effects of Z-ligustilide nanoemulsion.

Authors:  Zhaoji Ma; Lunhao Bai
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

6.  Development of a Solid Supersaturable Micelle of Revaprazan for Improved Dissolution and Oral Bioavailability Using Box-Behnken Design.

Authors:  Yoon Tae Goo; Cheol-Ki Sa; Ji Yeh Choi; Min Song Kim; Chang Hyun Kim; Hyeon Kyun Kim; Young Wook Choi
Journal:  Int J Nanomedicine       Date:  2021-02-17

7.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.

Authors:  Amalendu P Ranjan; Anindita Mukerjee; Lawrence Helson; Jamboor K Vishwanatha
Journal:  J Nanobiotechnology       Date:  2012-08-31       Impact factor: 10.435

8.  Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system.

Authors:  Zhi-Qiang Chen; Ying Liu; Ji-Hui Zhao; Lan Wang; Nian-Ping Feng
Journal:  Int J Nanomedicine       Date:  2012-02-23

9.  Characterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability.

Authors:  Yunrong Zhang; Li He; Shanlan Yue; Qingting Huang; Yuhong Zhang; Junyi Yang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Developing micro-/nanoparticulate drug delivery systems using "design of experiments".

Authors:  Bhupinder Singh; Rahul Bhatowa; Chandra Bhushan Tripathi; Rishi Kapil
Journal:  Int J Pharm Investig       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.